Clinical Trial Update: A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids. [Phase 2]

View source ↗

Summary

Phase 2 pharmacodynamic study of a gelatin-free leuprorelin formulation in women with uterine fibroids has completed. The trial was sponsored by Takeda.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Leuprorelin gelatin-free formulation (leuprorelin acetate)

Snippet

Sponsor: Takeda | Conditions: Uterine Fibroids | Phase 2 | Status: COMPLETED